Suppr超能文献

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的刺突蛋白(S蛋白)通过保守的S2亚基破坏ISGF3复合物的形成,以拮抗I型干扰素反应。

SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response.

作者信息

Cai Zeng, Ni Wenjia, Li Wenkang, Wu Zhixuan, Yao Xiaoqian, Zheng Yucheng, Zhao Yongliang, Yuan Weifeng, Liang Simeng, Wang Qi, Tang Mingliang, Chen Yu, Lan Ke, Zhou Li, Xu Ke

机构信息

State Key Laboratory of Virology, Taikang Center for Life and Medical Sciences, College of Life Sciences, Wuhan University, Wuhan, China.

Institute for Vaccine Research, Animal Biosafety Level 3 Laboratory, Wuhan University Centre for Animal Experiment, Wuhan, China.

出版信息

J Virol. 2025 Jan 31;99(1):e0151624. doi: 10.1128/jvi.01516-24. Epub 2024 Dec 19.

Abstract

UNLABELLED

Viral immunosuppression substantially affects the host immune response of infected patients and the protective efficacy of vaccines. Here, we found that the spike (S) protein, the major vaccine antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), strongly suppresses host innate immunity by inhibiting interferon-stimulated gene (ISG) expression through both S1 and S2 subunits. Mechanistically, the S protein inhibited the formation of the classic interferon-stimulated gene factor 3 (ISGF3) complex composed of STAT1, STAT2, and IRF9 by competing with STAT2 for binding to IRF9, thereby impeding the transcription of ISGs. A strong interaction between S and the STAT1/STAT2 proteins further traps the ISGF3 complex in the endoplasmic reticulum and hinders the nuclear translocation of ISGF3. Notably, the interferon-inhibitory mechanism of the S protein was universal among SARS-CoV-2 variants and other human coronaviruses, including SARS-CoV, Middle East respiratory syndrome coronavirus (MERS-CoV), human coronavirus 229E (HCoV-229E), human coronavirus NL63 (HCoV-NL63), and human coronavirus HKU1 (HCoV-HKU1), through the most evolutionarily conserved region of S2 subunit. Taken together, the findings of this study reveal a new mechanism by which the coronavirus S protein attenuates the host antiviral immune response and provides new insights into the proper design of coronavirus S-based vaccines to prevent immunosuppressive effects.

IMPORTANCE

This study unveils a new mechanism by which the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein attenuates the host's antiviral immune response. The interferon-inhibitory mechanism of the S protein was universal among SARS-CoV-2 variants and other human coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, and HCoV-HKU1, through conserved S2 domains. Our study expands the understanding of SARS-CoV-2 and other human coronaviruses in evading antiviral immune strategies, which is very important for the design and optimization of vaccine antigens, thus providing a theoretical basis for human anti-coronavirus immunity and understanding the interaction between the host and coronavirus.

摘要

未标记

病毒免疫抑制严重影响感染患者的宿主免疫反应以及疫苗的保护效力。在此,我们发现严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的主要疫苗抗原刺突(S)蛋白通过S1和S2亚基抑制干扰素刺激基因(ISG)的表达,从而强烈抑制宿主固有免疫。机制上,S蛋白通过与信号转导和转录激活因子2(STAT2)竞争结合干扰素调节因子9(IRF9),抑制由STAT1、STAT2和IRF9组成的经典干扰素刺激基因因子3(ISGF3)复合物的形成,从而阻碍ISG的转录。S与STAT1/STAT2蛋白之间的强相互作用进一步将ISGF3复合物截留在内质网中,并阻碍ISGF3的核转位。值得注意的是,S蛋白的干扰素抑制机制在SARS-CoV-2变体和其他人类冠状病毒中普遍存在,包括严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)、人类冠状病毒229E(HCoV-229E)、人类冠状病毒NL63(HCoV-NL63)和人类冠状病毒HKU1(HCoV-HKU1),通过S2亚基最具进化保守性的区域。综上所述,本研究结果揭示了冠状病毒S蛋白减弱宿主抗病毒免疫反应的新机制,并为基于冠状病毒S的疫苗的合理设计提供了新见解,以预防免疫抑制作用。

重要性

本研究揭示了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突(S)蛋白减弱宿主抗病毒免疫反应的新机制。S蛋白的干扰素抑制机制在SARS-CoV-2变体和其他人类冠状病毒中普遍存在,包括SARS-CoV、MERS-CoV、HCoV-229E、HCoV-NL63和HCoV-HKU1,通过保守的S2结构域。我们的研究扩展了对SARS-CoV-2和其他人类冠状病毒逃避抗病毒免疫策略的理解,这对于疫苗抗原的设计和优化非常重要,从而为人类抗冠状病毒免疫以及理解宿主与冠状病毒之间的相互作用提供了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efed/11784297/799d284385c8/jvi.01516-24.f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验